US Patent Issued to HANGZHOU CONVERD on June 16 for "Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers" (Chinese Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,851, issued on June 16, was assigned to HANGZHOU CONVERD Co. LTD. (Hangzhou, China).

"Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers" was invented by Jipo Sheng (Hangzhou, China), Jin Fu (Hangzhou, China), Ronghua Zhao (Hangzhou, China), Yun Qin (Hangzhou, China), Lin Chen (Hangzhou, China), Sanmao Kang (Hangzhou, China) and Fang Hu (Hangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides an isolated recombinant oncolytic adenovirus, a pharmaceutical composition, and uses thereof for drugs for treatment of tumors and/or...